Has Lance Silverman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,869 in general payments to Lance Silverman, MD across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lance Silverman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lance Silverman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lance Silverman, MD

Foot and Ankle Surgery · Roswell, GANPI 1609872159

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $14,641 of the $19,869 with a category attached, or 73.7%. Ossio Inc accounts for 76.6% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $9,678 and has fallen 66.1% since, to $3,281 in 2025. Among foot and ankle surgery clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,869in general payments, 2019–2025

Across 78 payments — averaging $254.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ossio Inc$15K
Stryker$2K
Arcuro Medical Inc$560
Treace Medical Concepts, Inc.$302
Acumed LLC$296
Arthrex$261
plus $1K from 18 others

What the payments were for

Consulting fees$14,64174%
Travel & lodging$470%
Food & beverage$5,18126%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ossio Inc	13	$15,220
Stryker(2 entities)	25	$1,793
Arcuro Medical Inc	1	$560
Treace Medical Concepts, Inc.	2	$302
Acumed LLC	4	$296
Arthrex	2	$261
Zimmer Biomet	4	$234
Integra Lifesciences Corporation	3	$224
Biotissue Holdings Inc.	1	$161
Vertex	2	$128
Foundation Medical, LLC	1	$112
Ossdsign USA Incorporated	1	$109
Orthofix Medical, Inc.	3	$87
Abanza Inc.	1	$70
Linvatec Corporation	1	$46
Stimwave Technologies Incorporated	3	$45
Smith+Nephew	2	$36
Paragon 28, Inc.	2	$33
Johnson & Johnson	1	$32
Aroa Biosurgery Incorporated	1	$29
Davol Inc.	2	$29
Bioventus LLC	1	$27
Arthrosurface Incorporated	1	$21
Misonix Inc	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTEGRA$590
INBONE$562
SUPERBALL$560
ACUMED$431
INFINITY$246
INTEGRA DERMAL REGENERATION TEMPLATE$197
PRIMATRIX$197
ANCHORAGE$171
TMC NANOPLASTY SYSTEM$162
CLARIX$161
LAPIPLASTY SYSTEM 1$140
PROSTEP MICA$128
Bone Healing Product Portfolio$123
PRIME SERIES$120
AUGMENT$114
OssDsign Catalyst$109
AUGMENT INJECTABLE$105

How this compares

$19,869 in reported general payments places this provider in the 90th percentile of 239 foot and ankle surgery providers in Georgia.

See all foot and ankle surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$50,085

Medicare patients

Services billed

375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	53	$1,656
CefuroximeCefuroxime Axetil	23	$316
Cyclobenzaprine Hcl	41	$193
Ondansetron OdtOndansetron	43	$125
Oxycodone Hcl	39	$106
Pregabalin	32	$103

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Roswell

Richard KaufmanRoswell$25K
Paris PaytonRoswell$7K
Robert WeinsteinFayetteville$394K
Jason BariteauAtlanta$199K
Scott RomanPeachtree City$118K
Jeffrey FlashForest Park$114K
Mickey StappThomson$110K
David MurphyWaycross$55K
Rishin KadakiaAtlanta$53K
Javan BassLithonia$43K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →